Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Positron Emission Tomography (PET) Using Hormone Receptor Ligands in Breast Cancer

This study has been completed.
United States Department of Defense
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center Identifier:
First received: March 28, 2008
Last updated: August 12, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)